Egyptian International Pharmaceutical Industries Company (EGX: PHAR)
Egypt
· Delayed Price · Currency is EGP 49.28
0.00 (0.00%)
At close: Oct 15, 2024
PHAR Cash Flow Statement
Financials in millions EGP. Fiscal year is January - December.
Millions EGP. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | 1,448 | 1,083 | 804.74 | 654.17 | 576.28 | 670.63 | Upgrade
|
| Depreciation & Amortization | 101.07 | 104.76 | 99.26 | 90.88 | 139.57 | 146.78 | Upgrade
|
| Other Amortization | 2.43 | 0.49 | - | - | - | - | Upgrade
|
| Loss (Gain) From Sale of Assets | -4.71 | -4.69 | -3.7 | -2.78 | -3.8 | -3.14 | Upgrade
|
| Loss (Gain) From Sale of Investments | -26.11 | -55.66 | -25.51 | - | - | - | Upgrade
|
| Loss (Gain) on Equity Investments | - | - | - | -43.37 | -37.18 | -45.83 | Upgrade
|
| Provision & Write-off of Bad Debts | 93.78 | 36.78 | 30.34 | - | - | - | Upgrade
|
| Other Operating Activities | -484.07 | -238.87 | -268.36 | -53.83 | -226.42 | -232.31 | Upgrade
|
| Change in Accounts Receivable | -968.15 | -613.4 | -567.8 | - | 106.5 | -405.57 | Upgrade
|
| Change in Inventory | -877.21 | -84.58 | -392.29 | -234.77 | -359.03 | 92.31 | Upgrade
|
| Change in Accounts Payable | -351.02 | -137.74 | 26.5 | -26.49 | -31.05 | 57.42 | Upgrade
|
| Operating Cash Flow | -1,066 | 90.35 | -296.81 | 383.82 | 164.86 | 280.3 | Upgrade
|
| Operating Cash Flow Growth | - | - | - | 132.81% | -41.18% | - | Upgrade
|
| Capital Expenditures | -2,573 | -2,290 | -562.95 | -437.09 | -203.56 | -177.11 | Upgrade
|
| Sale of Property, Plant & Equipment | 6.72 | 5.2 | 3.75 | 2.85 | 4.13 | 3.14 | Upgrade
|
| Investment in Securities | -87 | -84 | - | - | -79.77 | -211.53 | Upgrade
|
| Other Investing Activities | 71.53 | 39.35 | 29.41 | 62.88 | 72.75 | 105.16 | Upgrade
|
| Investing Cash Flow | -2,582 | -2,330 | -529.8 | -371.36 | -206.46 | -280.35 | Upgrade
|
| Short-Term Debt Issued | - | 3.54 | 813.48 | - | - | 453.61 | Upgrade
|
| Long-Term Debt Issued | - | 2,097 | 455.98 | 279.64 | 789.87 | - | Upgrade
|
| Total Debt Issued | 3,646 | 2,100 | 1,269 | 279.64 | 789.87 | 453.61 | Upgrade
|
| Long-Term Debt Repaid | - | -76.51 | -172.92 | -310.85 | - | - | Upgrade
|
| Net Debt Issued (Repaid) | 3,634 | 2,024 | 1,097 | -31.22 | 789.87 | 453.61 | Upgrade
|
| Issuance of Common Stock | 495.85 | 495.85 | - | - | - | - | Upgrade
|
| Repurchase of Common Stock | - | - | - | -12.58 | -89.86 | - | Upgrade
|
| Common Dividends Paid | -380.22 | -309.76 | -393.14 | -383.57 | -503.1 | -498.38 | Upgrade
|
| Other Financing Activities | 0 | 0 | - | - | - | - | Upgrade
|
| Financing Cash Flow | 3,750 | 2,210 | 703.41 | -427.37 | 196.91 | -44.77 | Upgrade
|
| Foreign Exchange Rate Adjustments | 507.17 | 222.29 | 294.58 | -6.25 | -11.55 | 21.79 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | - | - | - | - | - | 0 | Upgrade
|
| Net Cash Flow | 608.41 | 192.83 | 171.38 | -421.17 | 143.77 | -23.03 | Upgrade
|
| Free Cash Flow | -3,640 | -2,200 | -859.77 | -53.27 | -38.7 | 103.18 | Upgrade
|
| Free Cash Flow Margin | -57.38% | -42.05% | -21.74% | -1.56% | -1.34% | 3.03% | Upgrade
|
| Free Cash Flow Per Share | -24.47 | -14.79 | -8.67 | -0.54 | -0.40 | 1.04 | Upgrade
|
| Cash Interest Paid | 582.66 | 388.52 | 195.42 | - | 83.16 | 57 | Upgrade
|
| Cash Income Tax Paid | 88.84 | 89.36 | 59.92 | 136.25 | 107.69 | 189.23 | Upgrade
|
| Levered Free Cash Flow | - | -2,248 | -862.05 | -148.76 | -131.13 | -61.48 | Upgrade
|
| Unlevered Free Cash Flow | - | -2,005 | -739.91 | -63.61 | -79.15 | -25.85 | Upgrade
|
| Change in Net Working Capital | - | 576.85 | 689.97 | 202.93 | 382.23 | 433.48 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.